Camena Bioscience

About:

Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications.

Website: https://www.camenabio.com/

Twitter/X: camenabio

Top Investors: Mercia Asset Management

Description:

Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existing Phosphoramidite synthesis technology. Camena Bioscience was founded in 2016 and is headquartered in Cambridge.

Total Funding Amount:

7.9M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2016-01-01

Contact Email:

info(AT)camenabio.com

Founders:

Andy Fraser, Derek Stemple, Steve Harvey

Number of Employees:

11-50

Last Funding Date:

2023-07-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai